2024-04-23 08:30:00 ET
Summary
- UnitedHealth Group investors recently faced a rare bear market decline in UNH, which was hit by a series of unforeseen challenges.
- However, UnitedHealth management surprised the market by maintaining its 2024 adjusted EPS guidance.
- A robust post-earnings recovery suggests the market was too pessimistic heading into UnitedHealth's first-quarter earnings release.
- With UNH valued below its long-term average, I explain why UNH's long-term uptrend bias remains undefeated.
- UNH buyers looking to load up should capitalize on the recent reset and recovery before it resumes its recovery.
UnitedHealth Group ( UNH ) investors faced significant downside volatility in April. UNH was battered toward the $435 zone, representing more than a 20% decline from its November 2023 highs. As a result, UNH investors endured a momentary bear market decline in the stock of the leading integrated healthcare company. UNH investors have faced a series of disappointments since its Q4 release in January 2024. I upgraded UNH back then, assessing a more constructive risk/reward following the pullback from UNH's 2023 highs....
Read the full article on Seeking Alpha
For further details see:
UnitedHealth: The Recovery Is Just Getting Started